Communication

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

Education Reduces Distress During Breast Cancer Treatment

January 31, 2012

Physical, emotional, and social adjustment occurs over time with or without interventions
 

Should informed consent mean the patient understands?

January 30, 2012

The patient understood that surgery was the best next step in her treatment. Or, did she?
 

Parabens found in breast tumor tissue of nonusers of underarm products

January 30, 2012

Chemicals known as parabens, which may have a role in breast cancer and are commonly used as preservatives in cosmetics, food products, and pharmaceuticals, have now been found in measurable levels in the breast tissue of women who do not use underarm products.
 

Indices for early symptoms of ovarian cancer may need tweaking

January 27, 2012

The clinical utility of a symptom index for ovarian cancer depends on precisely how it is used and how index-positive women are managed, indicate the results of a recent study.
 

Distress: Measuring its relation to cancer diagnosis and treatment

Rosemarie A. Tucci, RN, MSN January 26, 2012

Nurses should assess cancer patients frequently and intervene promptly throughout the treatment course.
 

An exit strategy for opioid therapy

January 26, 2012

What exit strategy do you recommend for discontinuing opioid therapy?
 

Impact of CYP3A4 pathway

January 26, 2012

How does the CYP3A4 pathway impact metabolism of the new oral targeted agents in oncology?
 
ONA Newsletters
Sign up today for one of our free newsletters:
  • Issue Preview
  • Latest CE
  • Reflections
  • Editor's choice
  • New on the Web

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey

Cancer care is expensive.
CancerCare can help.


Connect Booklets
FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions